Savannah Partridge

Savannah Partridge is a medical physicist and breast imaging researcher who has made significant contributions to diffusion-weighted MRI for breast cancer detection, characterization, and treatment response monitoring. Her laboratory has developed quantitative DWI methods for breast cancer diagnosis and neoadjuvant chemotherapy response prediction, demonstrating that early ADC (apparent diffusion coefficient) changes predict pathological complete response before anatomic changes are visible. Partridge has contributed to ACRIN and iSPY trials evaluating breast MRI and DWI as response biomarkers in neoadjuvant breast cancer treatment, advancing imaging endpoints in breast cancer clinical trials.